Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.25M Buy
64,183
+2,204
+4% +$258K 0.32% 57
2026
Q1
$7.46M Sell
61,979
-1,063
-2% -$123K 0.35% 55
2025
Q4
$6.64M Sell
63,042
-267
-0.4% -$25.1K 0.31% 60
2025
Q3
$5.31M Buy
63,309
+2,304
+4% +$190K 0.28% 65
2025
Q2
$4.83M Sell
61,005
-1,571
-3% -$125K 0.28% 68
2025
Q1
$5.62M Sell
62,576
-2,143
-3% -$200K 0.36% 53
2024
Q4
$6.44M Sell
64,719
-838
-1% -$86.4K 0.4% 38
2024
Q3
$7.44M Buy
65,557
+3,195
+5% +$380K 0.48% 33
2024
Q2
$7.72M Sell
62,362
-214
-0.3% -$27.6K 0.55% 26
2024
Q1
$8.26M Buy
62,576
+39,638
+173% +$4.89M 0.5% 34
2023
Q4
$2.5M Buy
22,938
+7,890
+52% +$819K 0.46% 37
2023
Q3
$1.55M Sell
15,048
-490
-3% -$52.8K 0.29% 68
2023
Q2
$1.79M Buy
15,538
+2,287
+17% +$260K 0.32% 68
2023
Q1
$1.41M Buy
+13,251
New +$1.43M 0.29% 79

Other funds holding MRK

PFG Investments's MRK Position: Q2 2026 in Review

PFG Investments increased its Merck (MRK) stake by 3.6% in Q2 2026, buying an estimated $258K and bringing the position to 64,183 shares worth $8.25M. The position accounts for 0.32% of the portfolio, ranked #57.

PFG Investments first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.26M in Q1 2024. 1,635 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • PFG Investments held 64,183 shares of Merck worth $8.25M as of Q2 2026.
  • PFG Investments bought 2,204 Merck shares in Q2 2026, an estimated $258K.
  • Merck made up 0.32% of PFG Investments's portfolio in Q2 2026, its #57 holding.
  • PFG Investments first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • PFG Investments's Merck position peaked at $8.26M in Q1 2024.
  • 1,635 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.